Aanmeldingen op de spoeddienst omwille van recreatief druggebruik

Terug naar alle onderzoeken

Samenvatting

Drugs/NPS are commonly used across Europe and Emergency Room admissions with drug/NPS toxicity can result in significant morbidity and mortality. The EMCDDA collect drug indicator data but currently this did not include indicators relating to acute drug toxicity or Emergency Room admissions before the start of Euro-DEN. We have developed a representative minimum dataset that includes parameters to capture the most clinically important aspects of acute drug/NPS toxicity, with basic demographic information and data on drugs/NPS used. The Euro-DEN network uses the minimum dataset to establish the drugs and NPS responsible for Emergency Room admissions across Europe and the clinical patterns of acute toxicity. With these trends and patterns, we will be able to monitor include geographical and seasonal differences in the drugs/NPS used and patterns of acute toxicity; we will also be able to identify patterns of acute toxicity of emerging NPS. This information will be disseminated to a wide range of stakeholders including policy makers, healthcare professionals, academics in the drugs field and drugs workers.

The emergency departments of UZ Gent and ZNA Stuivenberg are the two Belgian centers which are part of the Euro-DEN registration.

In summary, Euro-DEN has developed a novel key indicator to enable real-time monitoring of drug/NPS acute toxicity, the morbidity and mortality associated with this toxicity.

Onderzoekspopulatie

Euro-DEN case definitions

For the purpose of data collection for the Euro-DEN project, the following case definition

will be used:

“An individual who presents to participating acute care facilities with symptoms and/or

signs consistent with acute recreational drug toxicity and/or directly related to

recreational drug use. Patients with a primary diagnosis of isolated ethanol intoxication

will be excluded (although those who co-ingest ethanol and present with recreational

drug toxicity will be included)”.

A recreational drug is defined as “a psychoactive compound that was taken for the

purpose of recreational activities rather than for medical or work purposes or as part of

(deliberate) self-harm”. The types of drugs, agents or activities to be included are:

• Established classified recreational drugs

• New (novel) psychoactive substances

• Plants, fungi or herbal/alternative medicines

• Use of licensed pharmaceutical preparations for recreational use

• Use of industrial and/or domestic products (i.e. solvents, glues, propellants

etc.) for recreational purposes

The recreational drug(s) associated with the presentation will be based on one or a

combination of the following:

i) the patient’s self-reported use;

ii) information retrieved from witnesses;

Euro-DEN data collection SOP v3 10th September 2013 2

iii) the opinion of the physician assessing the patient; and/or

iv) the toxicologist reviewing data entry/case records.

Case inclusion criteria

Any case in which a patient has symptoms and/or signs consistent with acute

recreational drug toxicity and/or directly related to acute recreational drug use should be

included in the data collection.

This will include a patient who presents to the Emergency Room (ER) because of

concerns about an acute episode of drug use, even if the patient has no clinical signs

on examination. The clinical symptoms the patient describes having experienced should

be recorded.

A patient who has been unwell prior to attendance to the ER but is found to have no

clinical signs on examination will also be included. The clinical symptoms and/or signs

the patient was witnessed to have had should be recorded (e.g. seizures in a nightclub).


Case exclusion criteria

A patient who attends the ER with any of the following presentations should be

excluded from the data collection:

• Lone alcohol ingestion or intoxication, including cases involving ‘spiked drinks’ (i.e.

drinks to which it is alleged a substance has been maliciously added) where

patients have no symptoms of acute recreational drug toxicity

• Symptoms and signs consistent with an alternate medical diagnosis and not

related to acute recreational drug toxicity

• Injury related to trauma, unless the trauma is directly related to drug use e.g. as a

result of hallucinations

• Drug or ethanol withdrawal

• Secondary complications of chronic drug use (e.g. infected injection sites,

HIV/HBV/HCV, endocarditis) and no evidence of acute recreational drug toxicity

• Secondary complications of previous acute drug use complications (e.g. previous

stroke secondary to hypertensive intracranial haemorrhage presenting with

aspiration pneumonia)

• An individual transferred through the ER for care to other areas of the participating

centres (e.g. intensive care, surgery etc.) and not for a primary emergency

evaluation


For example if a patient attends the ER requiring treatment because s/he has been

physically assaulted but it subsequently found s/he has used recreational drugs, the

patient should not be included in the study as the presenting complaint was not related

to the drug use.

Output

Jaarlijkse bijdrage aan het Europees Drugsrapport van de EMCDDA

Lyphout, C., Yates, C., Margolin, Z. R., Dargan, P. I., Dines, A. M., Heyerdahl, F., ... & Wood, D. M. (2019). Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data. European journal of clinical pharmacology, 75(1), 77-85


Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R, Dargan PI, Euro-DEN Research Group. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).. 2015 Nov;53(9):893-900. doi: 10.3109/15563650.2015.1088157.


Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE, Dargan PI. The European Drug Emergencies Network (Euro-DEN).
Clin Toxicol (Phila). 2014 Apr;52(4):239-41. doi: 10.3109/15563650.2014.898771. Epub 2014 Mar 21. No abstract available.


Dines AM, Wood DM, Galicia M, Yates CM, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R; Euro-DEN Research Group, Dargan PI. Presentations to the Emergency Department Following Cannabis use--a Multi-Centre Case Series from Ten European Countries. J Med Toxicol. 2015 Dec;11(4):415-21. doi: 10.1007/s13181-014-0460-x.


Vallersnes OM, Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I; Euro-DENResearch Group, Dargan PI. Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry. 2016 Aug 18;16:293. doi: 10.1186/s12888-016-1002-7.


Miró Ò, Galicia M, Dargan P, Dines AM, Giraudon I, Heyerdahl F, Hovda KE, Yates C, Wood DM, Liakoni E, Liechti M, Jürgens G, Pedersen CB, O'Connor N, Markey G, Moughty A, Lee C, O'Donohoe P, Sein Anand J, Puiguriguer J, Homar C, Eyer F, Vallersnes OM, Persett PS, Chevillard L, Mégarbane B, Paasma R, Waring WS, Põld K, Rabe C, Kabata PM. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicol Lett. 2017 Aug 5;277:84-91.


Yamamoto T, Dargan PI, Dines A, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R, Wood DM; Euro-DEN Research Group. Concurrent Use of Benzodiazepine by Heroin Users-What Are the Prevalence and the Risks Associated with This Pattern of Use? J Med Toxicol. 2019 Jan;15(1):4-11. doi: 10.1007/s13181-018-0674-4`


Liakoni E, Yates C, Dines AM, Dargan PI, Heyerdahl F, Hovda KE, Wood DM, Eyer F, Liechti ME; Euro-DEN Plus Research Group. Acute recreational drug toxicity: Comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series. Medicine (Baltimore). 2018 Feb;97(5):e9784.


Miró Ò, Dargan PI, Wood DM, Dines AM, Yates C, Heyerdahl F, Hovda KE, Giraudon I; Euro-DENPlus Research Group, Galicia M. Epidemiology, clinical features and management of patients presenting to European emergency departments with acute cocaine toxicity: comparison between powder cocaine and crack cocaine cases. Clin Toxicol (Phila). 2019 Aug;57(8):718-726.


Wolfe CE, Wood DM, Dines A, Whatley BP, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Dargan PI; Euro-DEN Research Group. Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set. Neurotoxicology. 2019 Jul;73:183-187.


Galicia M, Dargan PI, Dines AM, Yates C, Heyerdahl F, Hovda KE, Giraudon I; Euro-DEN Plus Research Group, Wood DM, Mirsó Ò; Euro-DEN Plus Research Group. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication. Toxicol Lett. 2019 Jul 10;314:37-42. doi: 10.1016/j.toxlet.2019.07.001.


The Euro-DEN Project: Guidelines on when to call the Emergency Services 112 for unwell recreational drug users

Contact

UZ Gent, Spoeddienst
Cathelijne .Lyphout

Algemene info

Looptijd

Startdatum 01/01/2017
Einddatum 31/12/2034
Doorlopend project

Product

Psychoactieve medicatie

Datum laatste wijziging: 17/08/2019
Dit item aanpassen